Clinic for Amyotrophic Lateral Sclerosis Treatment in Shenzhen

Shenzhen Beike Biotechnology uses mesenchymal stem cells to slow ALS and PLS progression by targeting central nervous system inflammation. The clinic holds AABB and CAP accreditations and maintains over 900 quality checkpoints for cell safety. Treatment options include a standard protocol with up to 8 injections over 23 days or a high-dose 8-day program. Every cycle provides between 120 million and 280 million cells. Therapy combines IV and intrathecal injections with daily rehabilitation, such as physiotherapy and hyperbaric oxygen therapy.